Panolos Bioscience Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
2ndary - Private
- Investors
-
8
Panolos Bioscience General Information
Description
Developer of multi-specific drug creation platform designed for cancer treatment. The company's platform offers anti-angiogenesis-based artifact re-targeting tri-specifics commonly called ART, reducing the side effects of single-target protein therapeutics, and is a platform for the expansion of new drug pipelines through multi-targeting, enabling patients with novel drugs and treatment for cancer.
Contact Information
Website
www.panolos.comCorporate Office
- 21 gil 10 Dongtandae-ro
- The First Tower, Suite#217
- Hwaseong, Gyeonggi 18471
- South Korea
Corporate Office
- 21 gil 10 Dongtandae-ro
- The First Tower, Suite#217
- Hwaseong, Gyeonggi 18471
- South Korea
Panolos Bioscience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Secondary Transaction - Private | Completed | Clinical Trials - Phase 1 | ||||
| 3. Early Stage VC (Series A) | 17-May-2021 | Completed | Clinical Trials - Phase 1 | |||
| 2. Early Stage VC | 01-Sep-2020 | $50.5M | $54.8M | Completed | Startup | |
| 1. Angel (individual) | 01-Feb-2020 | $4.28M | $4.28M | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Panolos Bioscience Comparisons
Industry
Financing
Details
Panolos Bioscience Competitors (1)
One of Panolos Bioscience’s competitors is Shattuck Labs, a Formerly VC-backed company based in Austin, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Shattuck Labs | Formerly VC-backed | Austin, TX |
Panolos Bioscience Signals
Panolos Bioscience Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cloud Ivy Investment | Corporation | Minority | ||
| Compa Ventures | Venture Capital | Minority | ||
| JL Partners | Venture Capital | Minority | ||
| K-Clavis | Asset Manager | Minority | ||
| KOC Partners | Venture Capital | Minority |
Panolos Bioscience FAQs
-
When was Panolos Bioscience founded?
Panolos Bioscience was founded in 2019.
-
Where is Panolos Bioscience headquartered?
Panolos Bioscience is headquartered in Hwaseong, South Korea.
-
What is the size of Panolos Bioscience?
Panolos Bioscience has 6 total employees.
-
What industry is Panolos Bioscience in?
Panolos Bioscience’s primary industry is Drug Discovery.
-
Is Panolos Bioscience a private or public company?
Panolos Bioscience is a Private company.
-
What is Panolos Bioscience’s current revenue?
The current revenue for Panolos Bioscience is .
-
How much funding has Panolos Bioscience raised over time?
Panolos Bioscience has raised $72.7M.
-
Who are Panolos Bioscience’s investors?
Cloud Ivy Investment, Compa Ventures, JL Partners, K-Clavis, and KOC Partners are 5 of 8 investors who have invested in Panolos Bioscience.
-
Who are Panolos Bioscience’s competitors?
Shattuck Labs is a competitor of Panolos Bioscience.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process